Trevena, Inc. Email Format
Biotechnology ResearchPennsylvania, United States11-50 Employees
Trevena, Inc. is a biotechnology research company based in Chesterbrook, Pennsylvania, focused on developing and commercializing medicines for central nervous system disorders. Its work centers on creating novel biopharmaceuticals and advancing programs that address CNS-related health challenges, with ongoing projects including TRV045 and TRV734, as well as developments related to OLINVYK data from clinical studies. The company targets patients and healthcare providers in the CNS space, aiming to bring new therapeutic options and advance mechanisms of action that could influence treatment approaches. Operating within the biopharmaceutical sector, Trevena positions itself as a developer of innovative CNS medicines, pursuing Phase 1 proof-of-concept work and other clinical investigations to evaluate efficacy and target engagement. The organization is headquartered in the Philadelphia metropolitan area and is described as a smaller biotechnology enterprise with a focus on research and development for CNS indications.